Ellevest Inc’s Arcus Biosciences RCUS Stock Holding History

Ellevest Inc’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2	Closed	–	–	1541
2021 Q2	$0	Hold	2	–	–	﹤0.01%	1387
2021 Q1	$0	Hold	2	–	–	﹤0.01%	1338
2020 Q4	$0	Sell	2 -5	-71%	-$121	﹤0.01%	1320
2020 Q3	$0	Buy	+7	New	+$156	﹤0.01%	1288

Other funds holding RCUS

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Ellevest Inc's RCUS Position: Q3 2021 in Review

Ellevest Inc sold out of Arcus Biosciences (RCUS) in Q3 2021, closing a stake of 2 shares.

Ellevest Inc first reported a position in RCUS in Q3 2020 and held it in 4 quarters. The position peaked at $0 in Q2 2021. 131 funds tracked by Wall St. Rank hold RCUS as of Q3 2021.

Ellevest Inc reported no remaining Arcus Biosciences position as of Q3 2021 after selling out during the quarter.
Ellevest Inc sold 2 Arcus Biosciences shares in Q3 2021.
Ellevest Inc first reported a position in Arcus Biosciences in Q3 2020 and held it in 4 quarters.
Ellevest Inc's Arcus Biosciences position peaked at $0 in Q2 2021.
131 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2021.

Based on Ellevest Inc's 13F filing for Q3 2021, filed 19 Oct 2021.